[go: up one dir, main page]

FI894225L - Etoposidloesningar. - Google Patents

Etoposidloesningar. Download PDF

Info

Publication number
FI894225L
FI894225L FI894225A FI894225A FI894225L FI 894225 L FI894225 L FI 894225L FI 894225 A FI894225 A FI 894225A FI 894225 A FI894225 A FI 894225A FI 894225 L FI894225 L FI 894225L
Authority
FI
Finland
Prior art keywords
etoposide
solutions
etoposide solutions
Prior art date
Application number
FI894225A
Other languages
English (en)
Other versions
FI894225A0 (fi
FI894225A7 (fi
Inventor
Richard G Corrao
Murray A Kaplan
Edward J Bara
Ismat Ullah
Shreeram Narahari Agharkar
Gururaj Bykadi
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FI894225A0 publication Critical patent/FI894225A0/fi
Publication of FI894225L publication Critical patent/FI894225L/fi
Publication of FI894225A7 publication Critical patent/FI894225A7/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI894225A 1988-09-12 1989-09-07 Etoposidiliuokset FI894225A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/243,392 US4927638A (en) 1986-10-08 1988-09-12 Etoposide solutions

Publications (3)

Publication Number Publication Date
FI894225A0 FI894225A0 (fi) 1989-09-07
FI894225L true FI894225L (fi) 1990-03-13
FI894225A7 FI894225A7 (fi) 1990-03-13

Family

ID=22918600

Family Applications (1)

Application Number Title Priority Date Filing Date
FI894225A FI894225A7 (fi) 1988-09-12 1989-09-07 Etoposidiliuokset

Country Status (14)

Country Link
US (1) US4927638A (fi)
EP (1) EP0359184B1 (fi)
JP (1) JPH02115126A (fi)
KR (1) KR900004322A (fi)
AT (1) ATE83150T1 (fi)
AU (1) AU616049B2 (fi)
DE (1) DE68903814T2 (fi)
DK (1) DK446889A (fi)
FI (1) FI894225A7 (fi)
GR (1) GR3006501T3 (fi)
IE (1) IE892898L (fi)
IL (1) IL91598A0 (fi)
PT (1) PT91682B (fi)
ZA (1) ZA896916B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910014122A (ko) * 1990-01-19 1991-08-31 디께다 가즈히꼬 에토포시드-2-디메틸아미노 화합물의 동결건조 제제
US5648474A (en) * 1991-10-08 1997-07-15 Bristol-Myers Squibb Crystalline etoposide 4'-phosphate diethanolate
JP3121080B2 (ja) * 1991-12-19 2000-12-25 アール・ピー・シーラー コーポレイション カプセル封入用溶液
EP1033128B2 (en) * 1993-09-28 2011-11-23 R.P. Scherer GmbH Soft gelatin capsule manufacture
US6335356B1 (en) 1994-01-07 2002-01-01 Sugen, Inc. Method of treating a patient by parenteral administration of a lipophilic compound
US5610173A (en) * 1994-01-07 1997-03-11 Sugen, Inc. Formulations for lipophilic compounds
CA2188297C (en) * 1994-04-28 2006-12-19 Frederick Herman Hausheer Lactone stable formulation of camptothecin or 7-ethyl camptothecin
AU6390096A (en) * 1995-07-20 1997-02-18 Pharmacia & Upjohn Company Stable clear solutions of non-steroidal anti-inflammatory drugs for incorporation into gelatin capsules
US6316479B1 (en) 1997-05-19 2001-11-13 Sugen, Inc. Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
AU4609200A (en) * 1999-01-28 2000-08-18 Shashikant Prabhudas Kurani Novel injectable antimalarial compositions of artemisinin
JP2004503511A (ja) * 2000-06-12 2004-02-05 スミスクライン・ビーチャム・コーポレイション 新規固体分散剤組成物
US20080171687A1 (en) * 2004-09-16 2008-07-17 Abraxis Bioscience, Inc. Compositions And Methods For The Preparation And Administration Of Poorly Water Soluble Drugs
WO2007123468A1 (en) * 2006-04-24 2007-11-01 Bruce Medical Ab Polymer-based anti-cancer agents
US9011843B2 (en) * 2006-12-14 2015-04-21 Master Supplements, Inc. Formulations including monovalent alginate to enhance effectiveness of administered digestive enzymes
US20110135702A1 (en) * 2009-12-09 2011-06-09 Hoffman Douglas R Sporicidal composition for clostridium difficile spores
US9578879B1 (en) 2014-02-07 2017-02-28 Gojo Industries, Inc. Compositions and methods having improved efficacy against spores and other organisms
US9277749B2 (en) 2014-02-07 2016-03-08 Gojo Industries, Inc. Compositions and methods with efficacy against spores and other organisms

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3219529A (en) * 1962-10-04 1965-11-23 American Cyanamid Co Stable tetracycline solutions
US3699230A (en) * 1971-03-12 1972-10-17 Robins Co Inc A H Dimethylisosorbide solvent for muscle relaxant drugs
US4082881A (en) * 1976-12-23 1978-04-04 E. R. Squibb & Sons, Inc. Topical and other type pharmaceutical formulations containing isosorbide carrier
US4228162A (en) * 1979-07-09 1980-10-14 Research Corporation Dimethyl isosorbide in liquid formulation of aspirin
WO1984001506A1 (en) * 1982-10-13 1984-04-26 Univ Birmingham Pharmaceutical preparations for use in antitumour therapy
US4713246A (en) * 1984-03-19 1987-12-15 Bristol-Myers Company Etoposide oral dosage form
NZ211078A (en) * 1984-03-19 1987-08-31 Bristol Myers Co Oral dosage form of etoposide
JPS60239414A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド溶液の変色抑制方法
JPS60239415A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド注射剤
JPS60239418A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド軟カプセル製剤
JPS61189230A (ja) * 1985-02-19 1986-08-22 Nippon Kayaku Co Ltd エトポシド製剤

Also Published As

Publication number Publication date
IE892898L (en) 1990-03-12
US4927638A (en) 1990-05-22
FI894225A0 (fi) 1989-09-07
PT91682B (pt) 1995-05-31
EP0359184A1 (en) 1990-03-21
ATE83150T1 (de) 1992-12-15
PT91682A (pt) 1990-03-30
AU616049B2 (en) 1991-10-17
DK446889D0 (da) 1989-09-11
KR900004322A (ko) 1990-04-12
ZA896916B (en) 1991-08-28
DE68903814D1 (de) 1993-01-21
EP0359184B1 (en) 1992-12-09
JPH02115126A (ja) 1990-04-27
AU4130189A (en) 1990-03-15
IL91598A0 (en) 1990-04-29
DK446889A (da) 1990-03-13
FI894225A7 (fi) 1990-03-13
GR3006501T3 (fi) 1993-06-30
DE68903814T2 (de) 1993-04-08

Similar Documents

Publication Publication Date Title
FI901985A0 (fi) Fototerapeutisk ljusstyranordning.
FI890822A0 (fi) Foer dropploesningar avsedd behaollare.
FI894225L (fi) Etoposidloesningar.
FI881228A0 (fi) Kalandreringsanlaeggning och -foerfarande.
FI880847A0 (fi) Ventilmekanism foer foerbraenningsmotor.
FI892302A0 (fi) Fotoinitiatorkopolymerer.
FI893541A0 (fi) Nytt uttryckningssystem.
FI893577L (fi) Vaeteperoxidkompositioner innehaollande en substituerad aminobensaldehyd.
ES1007332Y (es) Pastillero.
FI881549A7 (fi) Saekerhetslaos.
FI892077A7 (fi) Polyeterantibioticum.
FI890892A0 (fi) B-amylasgen.
FI880487A0 (fi) Luftombytelucka.
FI893942L (fi) Faktorreglerande genexpression.
FI881093A0 (fi) Svetsningspinne.
ES1007733Y (es) Arqueta.
DE68906677D1 (de) Tc-99-m-komplexe.
ES1008248Y (es) Billar-bolera.
ES1006596Y (es) Medias-braga.
FI880347A0 (fi) Faergsticka.
FI881460A0 (fi) Mittlinjereflektor.
FI880922A0 (fi) Halkskydd.
FI910617A0 (fi) Fiskrensningsanordning.
FI880011A0 (fi) Skruvinmatare.
FI881671A0 (fi) Vibrationbestaendighetsprovanordning foer flaektblad.

Legal Events

Date Code Title Description
FA Application withdrawn [patent]

Owner name: BRISTOL-MYERS SQUIBB COMPANY